Lagniappe Labs LLC, provider of the Prime Unicorn™ Index family, including the Prime Unicorn™ Composite Index and the Prime Unicorn™ 30 Index, ...
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopaHop ...